Adolescent Medicine
Latest News
Nemolizumab Benefits Seen in Adults, Teens With Atopic Dermatitis
Significant improvements in pruritus were observed as early as week 1, with a greater proportion of participants in the nemolizumab vs placebo...
Latest News
Study Identifies Oral Antibiotics Linked to Severe Cutaneous Reactions
The results “underscore the importance of judicious prescribing, with preferential use of antibiotics associated with a lower risk when clinically...
Latest News
Skin Dxs in Children in Refugee Camps Include Fungal Infections, Leishmaniasis
In a study of 125 children at a Sierra Leone–based displacement camp, the prevalence of scabies was 77% among those aged < 5 years and 86%...
Latest News
Study Finds Gout Drug Effective for Aphthous Ulcers in Children
“Complex aphthous stomatitis in children is typically treated with topical supportive care, which is often not effective,” one of the study...
Latest News
Waiting for Therapy? There’s an App for That
The magnitude of change was not significantly different across the five arms on most measures and the groups did not differ in decrease of anxiety...
Latest News
Introducing: A New Way to Get Teens Mental Health Care
Pediatric urgent care mental health centers provide specialized care without the wait or environment of the emergency department.
Latest News
Emergency Contraception Recommended for Teens on Isotretinoin
Types of EC include oral levonorgestrel (plan B), oral ulipristal acetate (ella),...
Latest News
Topical Ruxolitinib: Analysis Finds Repigmentation Rates in Adolescents with Vitiligo
“Ruxolitinib cream can effectively and safely help many patients repigment, including adolescents,” David Rosmarin, MD, said.
Latest News
Two New Studies on Benzoyl Peroxide Provide Reassuring Data on Safety
Two
Latest News
Study Detects Bacteria in Tattoo, Permanent Makeup Inks
Of the 75 ink samples tested, 26 were contaminated with 34 bacterial isolates classified into 14 genera and 22 species.
Latest News
Study Finds Potential benefits of Spironolactone for Women with HS
The retrospective study included 157 women with HS who received spironolactone for at least 3 months.